Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
M Talpaz, RT Silver, BJ Druker… - Blood, The Journal …, 2002 - ashpublications.org
Chronic myelogenous leukemia (CML) is caused by expression of the BCR-ABL tyrosine
kinase oncogene, the product of the t (9; 22) Philadelphia translocation. Patients with CML in …
kinase oncogene, the product of the t (9; 22) Philadelphia translocation. Patients with CML in …
[PDF][PDF] Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
M Talpaz, RT Silver, BJ Druker, JM Goldman… - BLOOD, 2002 - msubiology.info
Accelerated phase marks the onset of advanced, rapidly progressive chronic myelogenous
leukemia (CML), a clonal neoplastic disorder of hematopoietic stem cells. 1, 2 In more than …
leukemia (CML), a clonal neoplastic disorder of hematopoietic stem cells. 1, 2 In more than …
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.
M Talpaz, RT Silver, BJ Druker, JM Goldman… - Blood, 2002 - europepmc.org
Chronic myelogenous leukemia (CML) is caused by expression of the BCR-ABL tyrosine
kinase oncogene, the product of the t (9; 22) Philadelphia translocation. Patients with CML in …
kinase oncogene, the product of the t (9; 22) Philadelphia translocation. Patients with CML in …
[引用][C] Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
M TALPAZ, RT SILVER, A HOCHHAUS… - Blood, 2002 - pascal-francis.inist.fr
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated
phase chronic myeloid leukemia: results of a phase 2 study CNRS Inist Pascal-Francis CNRS …
phase chronic myeloid leukemia: results of a phase 2 study CNRS Inist Pascal-Francis CNRS …
[引用][C] Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
M TALPAZ - Blood, 2002 - cir.nii.ac.jp
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated
phase chronic myeloid leukemia : results of a phase 2 study | CiNii Research CiNii 国立情報学 …
phase chronic myeloid leukemia : results of a phase 2 study | CiNii Research CiNii 国立情報学 …
[HTML][HTML] Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
M Talpaz, RT Silver, BJ Druker, JM Goldman… - Blood, 2002 - Elsevier
Chronic myelogenous leukemia (CML) is caused by expression of the BCR-ABL tyrosine
kinase oncogene, the product of the t (9; 22) Philadelphia translocation. Patients with CML in …
kinase oncogene, the product of the t (9; 22) Philadelphia translocation. Patients with CML in …
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: Results of a phase 2 study
M Talpaz, RT Silver, BJ Druker, JM Goldman… - …, 2002 - mdanderson.elsevierpure.com
Chronic myelogenous leukemia (CML) is caused by expression of the BCR-ABL tyrosine
kinase oncogene, the product of the t (9; 22) Philadelphia translocation. Patients with CML in …
kinase oncogene, the product of the t (9; 22) Philadelphia translocation. Patients with CML in …
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
M Talpaz, RT Silver, BJ Druker, JM Goldman… - …, 2002 - pubmed.ncbi.nlm.nih.gov
Chronic myelogenous leukemia (CML) is caused by expression of the BCR-ABL tyrosine
kinase oncogene, the product of the t (9; 22) Philadelphia translocation. Patients with CML in …
kinase oncogene, the product of the t (9; 22) Philadelphia translocation. Patients with CML in …
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: Results of a phase 2 study
M Talpaz, RT Silver, BJ Druker, JM Goldman… - Blood, 2002 - ohsu.elsevierpure.com
Chronic myelogenous leukemia (CML) is caused by expression of the BCR-ABL tyrosine
kinase oncogene, the product of the t (9; 22) Philadelphia translocation. Patients with CML in …
kinase oncogene, the product of the t (9; 22) Philadelphia translocation. Patients with CML in …
[引用][C] Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
M TALPAZ - Blood, 2002 - cir.nii.ac.jp
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated
phase chronic myeloid leukemia : results of a phase 2 study | CiNii Research CiNii 国立情報学 …
phase chronic myeloid leukemia : results of a phase 2 study | CiNii Research CiNii 国立情報学 …